Cheng Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cheng Shen has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Weihao Chen
West China School of Medicine, West-China Hospital, Sichuan University, Chengdu, 610041, China
5 shared publicationsJie Zhang
Department of Thoracic Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China
4 shared publicationsYuanyuan Yin
Department of Thoracic Surgery, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China
4 shared publications- Guowei Che
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
3 shared publications Kaidi Li
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
3 shared publicationsMengni Zhang
Department of Pathology, West China Hospital, Sichuan University, Chengdu, China
3 shared publications
Latest Publications
- 30 September 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (63)
Bioinspired Interlocking Hierarchical Heterostructures Endow Iontronic Pressure Sensors With Superior Strain Insensitivity, Air Permeability, and Sensing Performance for Neurodegenerative Disease Assessment
Pressure sensors, with their immense potential for detecting fine physiological activities and monitoring neurological disease‐related signals, face significant challenges, including the occurrence of signal artifacts during stretching and low comfort due to poor breathability. Here, a bioinspired interlocking hierarchical heterostructure (BIHH) is synergistically designed by anchoring a porous textile‐microstructured ionogel to stretchable laser‐induced graphene electrodes to simultaneously enhance strain insensitivity, pressure sensing performance, and wearable comfort. This modulus‐gradient heterogeneous mechanical network induces interfacial strain partitioning: tensile strain dissipates along porous Ecoflex frameworks, while the pressure‐sensitive domains are mechanically locked against deformation. Consequently, the sensor exhibits a mere 2% signal variation under 100% strain, maintaining consistent sensing capability even under severe stretching. Meanwhile, the hierarchical porous microstructure reconciles high‐performance iontronic pressure sensing with skin‐conformable breathability for array‐based touch and human physiological signal perception. Furthermore, by integrating artificial intelligence recognition algorithms, a five‐channel finger tapping assessment system achieves an accuracy of 97% in distinguishing different tapping patterns for the early auxiliary screening and rehabilitation of neurodegenerative diseases. This effective strategy opens a promising path for designing devices that reduce motion artifact interference while enhancing pressure sensing performance and comfort for on‐skin physiological activity monitoring.
- 30 September 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (63)
Bioinspired Interlocking Hierarchical Heterostructures Endow Iontronic Pressure Sensors With Superior Strain Insensitivity, Air Permeability, and Sensing Performance for Neurodegenerative Disease Assessment
Pressure sensors, with their immense potential for detecting fine physiological activities and monitoring neurological disease‐related signals, face significant challenges, including the occurrence of signal artifacts during stretching and low comfort due to poor breathability. Here, a bioinspired interlocking hierarchical heterostructure (BIHH) is synergistically designed by anchoring a porous textile‐microstructured ionogel to stretchable laser‐induced graphene electrodes to simultaneously enhance strain insensitivity, pressure sensing performance, and wearable comfort. This modulus‐gradient heterogeneous mechanical network induces interfacial strain partitioning: tensile strain dissipates along porous Ecoflex frameworks, while the pressure‐sensitive domains are mechanically locked against deformation. Consequently, the sensor exhibits a mere 2% signal variation under 100% strain, maintaining consistent sensing capability even under severe stretching. Meanwhile, the hierarchical porous microstructure reconciles high‐performance iontronic pressure sensing with skin‐conformable breathability for array‐based touch and human physiological signal perception. Furthermore, by integrating artificial intelligence recognition algorithms, a five‐channel finger tapping assessment system achieves an accuracy of 97% in distinguishing different tapping patterns for the early auxiliary screening and rehabilitation of neurodegenerative diseases. This effective strategy opens a promising path for designing devices that reduce motion artifact interference while enhancing pressure sensing performance and comfort for on‐skin physiological activity monitoring.
- 5 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (56)
An On‐Skin Visually Monitorable Gel‐Matrix Zinc–Ion Battery for Electrically Stimulated Wound Healing
Aqueous zinc‐ion batteries (ZIBs) feature intrinsic safety, low cost, and environmental compatibility, making them attractive for untapped cutting‐edge applications, such as the biomedicine area. Particularly, wearable medical power sources require stable electrical output, mechanical flexibility, and high biocompatibility. Herein, a stable and flexible gel‐matrix aqueous ZIB was designed as an on‐skin power source for electrically stimulated wound healing. The elaborately designed graded porous framework hydrogel electrolyte (GPF‐HGE) obtains high ionic conductivity (17.19 mS cm −1 ) and improved mechanical deformation tolerance (46 kPa and 205 J m −2 ) due to the porous framework formed in the solvent exchange process. Its transparency property, combined with an annular ring‐shaped electrode that generates an electric field aligned with the endogenous wound electric field, enables direct application to wound sites and real‐time visual monitoring. The assembled Zn|GPF‐HGE|I 2 @AC full cells show superior long‐term cycling stability accompanied by slight capacity fading, ensuring a steady energy supply for electrical stimulation (ES). Benefiting from its robust electrochemical stability and excellent biocompatibility, the obtained ES device can provide reliable electrical signals and promote wound healing through synergistic antibacterial and anti‐inflammatory effects. This work highlights the potential of aqueous ZIBs as advanced biomedical power sources beyond conventional energy storage applications.
- 5 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (56)
An On‐Skin Visually Monitorable Gel‐Matrix Zinc–Ion Battery for Electrically Stimulated Wound Healing
Aqueous zinc‐ion batteries (ZIBs) feature intrinsic safety, low cost, and environmental compatibility, making them attractive for untapped cutting‐edge applications, such as the biomedicine area. Particularly, wearable medical power sources require stable electrical output, mechanical flexibility, and high biocompatibility. Herein, a stable and flexible gel‐matrix aqueous ZIB was designed as an on‐skin power source for electrically stimulated wound healing. The elaborately designed graded porous framework hydrogel electrolyte (GPF‐HGE) obtains high ionic conductivity (17.19 mS cm −1 ) and improved mechanical deformation tolerance (46 kPa and 205 J m −2 ) due to the porous framework formed in the solvent exchange process. Its transparency property, combined with an annular ring‐shaped electrode that generates an electric field aligned with the endogenous wound electric field, enables direct application to wound sites and real‐time visual monitoring. The assembled Zn|GPF‐HGE|I 2 @AC full cells show superior long‐term cycling stability accompanied by slight capacity fading, ensuring a steady energy supply for electrical stimulation (ES). Benefiting from its robust electrochemical stability and excellent biocompatibility, the obtained ES device can provide reliable electrical signals and promote wound healing through synergistic antibacterial and anti‐inflammatory effects. This work highlights the potential of aqueous ZIBs as advanced biomedical power sources beyond conventional energy storage applications.
- Open Access
- 6 July 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
A new paradigm for esophageal disease management: the application and future prospects of Shared Decision Making (SDM)
Shared Decision Making (SDM), as a “patient-centered” medical decision-making model, has gradually demonstrated its application value in the di
- 6 July 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Open AccessA new paradigm for esophageal disease management: the application and future prospects of Shared Decision Making (SDM)
Shared Decision Making (SDM), as a “patient-centered” medical decision-making model, has gradually demonstrated its application value in the di
- 19 June 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Preoperative and intraoperative localization of small pulmonary nodules for thoracoscopic surgery: a contemporary narrative review
For thoracoscopic resection to be successful, accurate preoperative and intraoperative localization is necessary due to the growing detection of small, non-palpable lung nodules using low-dose CT scanning. Accurate localization is required rather than optional in robot-assisted thoracic surgery (RATS) since the total lack of tactile feedback makes it extremely difficult to identify deep, tiny, and subsolid nodules. With a focus on RATS-specific criteria, this study offers a modern, clinically focused framework for technique selection. This is a narrative review of the current literature. A structured literature search was conducted in PubMed, Embase, and Web of Science from January 2015 to May 2026, and 116 relevant articles were included for qualitative synthesis. We summarized the principles, clinical efficacy, complications, and RATS‑specific adaptability of CT-guided percutaneous, bronchoscopy-assisted, and intraoperative localization techniques. No quantitative meta-analysis or bias risk assessment was performed in this study. Nodule traits, patient considerations, and institutional resources should all be taken into consideration when choosing a technique. Although percutaneous techniques have a high success rate (88-100%), there is a risk of bleeding and pneumothorax (up to 40%). First-line options for RATS are indocyanine green (ICG) fluorescence marking and microcoil localization. ICG uses robotic near-infrared channels to achieve 100% intraoperative identification and R0 resection rates, while microcoils allow sublobar resection in 90.6% of patients with 100% R0 resection. Transbronchial approaches (virtual bronchoscopic navigation [VBN], electromagnetic navigation bronchoscopy [ENB]) eliminate external marker interference and greatly lower the incidence of pneumothorax (88% reduction, 3.3% vs. 28.3% for CT-guided transthoracic aspiration, P < 0.001). Electromagnetic interference is completely avoided in next-generation shape-sensing robotic bronchoscopy. Single-stage hybrid operating room methods are favored by workflow integration. Resource-stratified approaches are suggested: low-resource settings may employ VBN/VAL-MAP or percutaneous methylene blue; mid-resource centers benefit from ENB/VBN with ICG; high-resource centers may use single-stage cone-beam CT or robotic bronchoscopy. The best RATS-compatible selection is guided by the "three-zero" approach (zero external indicators, zero transport danger, and zero electromagnetic interference). Nodule traits, patient considerations, and institutional resources must all be considered when choosing a localization technique. Precise localization is required in RATS in order to maintain negative margins, lower conversion rates, and make up for tactile deficiencies. The best balance is frequently achieved using multimodal techniques. Further increases in pulmonary nodule localization accuracy, safety, and workflow efficiency are anticipated due to ongoing advancements in robotic bronchoscopy, hybrid operating rooms, and artificial intelligence.
- 19 June 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Preoperative and intraoperative localization of small pulmonary nodules for thoracoscopic surgery: a contemporary narrative review
For thoracoscopic resection to be successful, accurate preoperative and intraoperative localization is necessary due to the growing detection of small, non-palpable lung nodules using low-dose CT scanning. Accurate localization is required rather than optional in robot-assisted thoracic surgery (RATS) since the total lack of tactile feedback makes it extremely difficult to identify deep, tiny, and subsolid nodules. With a focus on RATS-specific criteria, this study offers a modern, clinically focused framework for technique selection. This is a narrative review of the current literature. A structured literature search was conducted in PubMed, Embase, and Web of Science from January 2015 to May 2026, and 116 relevant articles were included for qualitative synthesis. We summarized the principles, clinical efficacy, complications, and RATS‑specific adaptability of CT-guided percutaneous, bronchoscopy-assisted, and intraoperative localization techniques. No quantitative meta-analysis or bias risk assessment was performed in this study. Nodule traits, patient considerations, and institutional resources should all be taken into consideration when choosing a technique. Although percutaneous techniques have a high success rate (88-100%), there is a risk of bleeding and pneumothorax (up to 40%). First-line options for RATS are indocyanine green (ICG) fluorescence marking and microcoil localization. ICG uses robotic near-infrared channels to achieve 100% intraoperative identification and R0 resection rates, while microcoils allow sublobar resection in 90.6% of patients with 100% R0 resection. Transbronchial approaches (virtual bronchoscopic navigation [VBN], electromagnetic navigation bronchoscopy [ENB]) eliminate external marker interference and greatly lower the incidence of pneumothorax (88% reduction, 3.3% vs. 28.3% for CT-guided transthoracic aspiration, P < 0.001). Electromagnetic interference is completely avoided in next-generation shape-sensing robotic bronchoscopy. Single-stage hybrid operating room methods are favored by workflow integration. Resource-stratified approaches are suggested: low-resource settings may employ VBN/VAL-MAP or percutaneous methylene blue; mid-resource centers benefit from ENB/VBN with ICG; high-resource centers may use single-stage cone-beam CT or robotic bronchoscopy. The best RATS-compatible selection is guided by the "three-zero" approach (zero external indicators, zero transport danger, and zero electromagnetic interference). Nodule traits, patient considerations, and institutional resources must all be considered when choosing a localization technique. Precise localization is required in RATS in order to maintain negative margins, lower conversion rates, and make up for tactile deficiencies. The best balance is frequently achieved using multimodal techniques. Further increases in pulmonary nodule localization accuracy, safety, and workflow efficiency are anticipated due to ongoing advancements in robotic bronchoscopy, hybrid operating rooms, and artificial intelligence.
- Open Access
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1742160
Beyond traditional staging system: Tumor-Node-Metastasis-Blood staging system improves treatment decisions and prognostic stratification in cancer patients
Background: The traditional Tumor-Node-Metastasis (TNM) staging system for solid tumors relies on anatomical assessment but possesses inherent limitations in capturing systemic micrometastases and molecular-level disease burden. Recently, the Tumor-Node-Metastasis-Blood (TNMB) staging system has garnered significant attention. It aims to provide a systematic synthesis of the origin of the TNMB staging system, its current applications in tumors, and its future prospects, while evaluating its potential value in enhancing early diagnosis, prognostic assessment, and the precision of therapeutic decision-making. Methods: A systematic literature search was conducted in PubMed and Web of Science databases from 2018 to 2026 using keywords related to neoplasms and TNMB staging system. Articles were screened for inclusion, and 21 studies focusing on cutaneous T-cell lymphoma and lung cancer were included for analysis. Results: The TNMB staging system enhances risk stratification and prognostic accuracy in both cutaneous T-cell lymphoma and non-small cell lung cancer. In cutaneous lymphoma, TNMB staging system correlates with disease progression, treatment response, and molecular biomarkers. In lung cancer, integrating circulating tumor DNA (ctDNA) into TNMB staging system improves recurrence prediction and guides adjuvant therapy decisions, outperforming traditional TNM staging in prognostic discrimination. Beyond CTCL and non-small cell lung cancer (NSCLC), the utility of key biomarkers such as ctDNA for refining staging precision suggests a broader potential for the TNMB framework, even in cancers where its formal application is still forthcoming. Conclusion: The TNMB staging system represents a transformative approach in oncology by incorporating blood-based molecular data into traditional anatomical staging. It enables earlier detection of micrometastases, improves risk stratification, and supports personalized treatment strategies. Despite challenges in standardization and clinical integration, TNMB staging system holds significant promise for advancing precision oncology across multiple cancer types.
- 27 March 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1742160
Open AccessBeyond traditional staging system: Tumor-Node-Metastasis-Blood staging system improves treatment decisions and prognostic stratification in cancer patients
Background: The traditional Tumor-Node-Metastasis (TNM) staging system for solid tumors relies on anatomical assessment but possesses inherent limitations in capturing systemic micrometastases and molecular-level disease burden. Recently, the Tumor-Node-Metastasis-Blood (TNMB) staging system has garnered significant attention. It aims to provide a systematic synthesis of the origin of the TNMB staging system, its current applications in tumors, and its future prospects, while evaluating its potential value in enhancing early diagnosis, prognostic assessment, and the precision of therapeutic decision-making. Methods: A systematic literature search was conducted in PubMed and Web of Science databases from 2018 to 2026 using keywords related to neoplasms and TNMB staging system. Articles were screened for inclusion, and 21 studies focusing on cutaneous T-cell lymphoma and lung cancer were included for analysis. Results: The TNMB staging system enhances risk stratification and prognostic accuracy in both cutaneous T-cell lymphoma and non-small cell lung cancer. In cutaneous lymphoma, TNMB staging system correlates with disease progression, treatment response, and molecular biomarkers. In lung cancer, integrating circulating tumor DNA (ctDNA) into TNMB staging system improves recurrence prediction and guides adjuvant therapy decisions, outperforming traditional TNM staging in prognostic discrimination. Beyond CTCL and non-small cell lung cancer (NSCLC), the utility of key biomarkers such as ctDNA for refining staging precision suggests a broader potential for the TNMB framework, even in cancers where its formal application is still forthcoming. Conclusion: The TNMB staging system represents a transformative approach in oncology by incorporating blood-based molecular data into traditional anatomical staging. It enables earlier detection of micrometastases, improves risk stratification, and supports personalized treatment strategies. Despite challenges in standardization and clinical integration, TNMB staging system holds significant promise for advancing precision oncology across multiple cancer types.
- Open Access
- 24 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
The diagnostic value of serum Cystatin C in differentiating malignant from benign pulmonary nodules: a retrospective cohort study
The present study aims to evaluate the utility of Cystatin C testing for differentiating lung cancer from benign nodules of the lung in patient. Consecutiv
- 24 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessThe diagnostic value of serum Cystatin C in differentiating malignant from benign pulmonary nodules: a retrospective cohort study
The present study aims to evaluate the utility of Cystatin C testing for differentiating lung cancer from benign nodules of the lung in patient. Consecutiv
- Open Access
- 9 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 457
Woman in her seventh decade with huge heart in thorax
This article reports a case of a 70-year-old female patient with severe tricuspid regurgitation (TR), aiming to supplement clinical data on isolated severe tricuspid insufficiency in elderly patients and provide references for etiological exploration and clinical decision-making (Writing Committee Members in J Am Coll Cardiol 77(4):e25-197, 2021). The patient had an 18-year history of recurrent bilateral lower extremity edema and a 3-year history of exertional fatigue and shortness of breath. Clinical examinations included echocardiography and enhanced chest computed tomography (CT). Echocardiography showed right atrial and ventricular enlargement, severe tricuspid regurgitation, and normal left ventricular systolic function; enhanced chest CT indicated significant enlargement of the heart (predominantly right atrium and ventricle), calcification of the aorta and coronary arteries, and a mass in the lower lobe of the right lung. The final diagnosis was severe tricuspid regurgitation (secondary to right heart dilation and tricuspid annulus dilatation), sinus rhythm, grade III cardiac function, and a right lower lung mass (nature to be determined) (Coisne et al. in J Am Coll Cardiol 82(8):721-34, 2023). Due to poor lung function and elevated arterial carbon dioxide partial pressure, the patient could not tolerate surgical treatment and was discharged with medication and follow-up recommendations. This case highlights the complexity of etiological diagnosis in elderly patients with isolated severe tricuspid insufficiency and the importance of comprehensive clinical assessment for treatment strategy formulation.
- 9 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 457
Open AccessWoman in her seventh decade with huge heart in thorax
This article reports a case of a 70-year-old female patient with severe tricuspid regurgitation (TR), aiming to supplement clinical data on isolated severe tricuspid insufficiency in elderly patients and provide references for etiological exploration and clinical decision-making (Writing Committee Members in J Am Coll Cardiol 77(4):e25-197, 2021). The patient had an 18-year history of recurrent bilateral lower extremity edema and a 3-year history of exertional fatigue and shortness of breath. Clinical examinations included echocardiography and enhanced chest computed tomography (CT). Echocardiography showed right atrial and ventricular enlargement, severe tricuspid regurgitation, and normal left ventricular systolic function; enhanced chest CT indicated significant enlargement of the heart (predominantly right atrium and ventricle), calcification of the aorta and coronary arteries, and a mass in the lower lobe of the right lung. The final diagnosis was severe tricuspid regurgitation (secondary to right heart dilation and tricuspid annulus dilatation), sinus rhythm, grade III cardiac function, and a right lower lung mass (nature to be determined) (Coisne et al. in J Am Coll Cardiol 82(8):721-34, 2023). Due to poor lung function and elevated arterial carbon dioxide partial pressure, the patient could not tolerate surgical treatment and was discharged with medication and follow-up recommendations. This case highlights the complexity of etiological diagnosis in elderly patients with isolated severe tricuspid insufficiency and the importance of comprehensive clinical assessment for treatment strategy formulation.
- Open Access
Integrating Surgery and Ablative Therapies for the Management of Multiple Primary Lung Cancer: A Systematic Review
Background: Multiple primary lung cancer (MPLC) presents clinical challenges due to its biological complexity. While lobectomy remains standard, limited resection and localized ablation offer comparable efficacy. This systematic review evaluates the safety and efficacy of combining surgical and ablative therapies for MPLC. Methods: A comprehensive search of PubMed, Embase, and Web of Science (January 2000–2025) identified studies involving MPLC patients treated with both surgery and ablation, either concurrently or sequentially. Data on ablation efficacy, adverse events, and prognosis were extracted. A meta-analysis was performed when data pooling was appropriate. The methodological quality and risk of bias of the included studies were assessed using the MINORS and ROBINS-I tools. Publication bias was evaluated through funnel plots and Egger’s linear regression test. Furthermore, one case report on combination therapy was also included. Results: A total of nine studies met the inclusion criteria and were included in the final analysis. All reported a 100% technical success rate for ablation, efficacy rates exceeding 70%, and adverse event rates ranging from 5.0% to 26.7%. Due to significant heterogeneity among studies, a random-effects model was applied. The meta-analysis yielded a pooled ablation efficacy rate of 97.11% (95% CI: 85.81–100.00%) and a pooled adverse event rate of 14.23% (95% CI: 8.07–20.38%), indicating favorable safety and efficacy of the combined therapy. Conclusions: The integration of surgical and ablative therapies offers a safe and effective strategy for managing MPLC and supports a potential paradigm shift from single-modality treatment toward a more personalized, organ-preserving, and patient-centered approach.
Open AccessIntegrating Surgery and Ablative Therapies for the Management of Multiple Primary Lung Cancer: A Systematic Review
Background: Multiple primary lung cancer (MPLC) presents clinical challenges due to its biological complexity. While lobectomy remains standard, limited resection and localized ablation offer comparable efficacy. This systematic review evaluates the safety and efficacy of combining surgical and ablative therapies for MPLC. Methods: A comprehensive search of PubMed, Embase, and Web of Science (January 2000–2025) identified studies involving MPLC patients treated with both surgery and ablation, either concurrently or sequentially. Data on ablation efficacy, adverse events, and prognosis were extracted. A meta-analysis was performed when data pooling was appropriate. The methodological quality and risk of bias of the included studies were assessed using the MINORS and ROBINS-I tools. Publication bias was evaluated through funnel plots and Egger’s linear regression test. Furthermore, one case report on combination therapy was also included. Results: A total of nine studies met the inclusion criteria and were included in the final analysis. All reported a 100% technical success rate for ablation, efficacy rates exceeding 70%, and adverse event rates ranging from 5.0% to 26.7%. Due to significant heterogeneity among studies, a random-effects model was applied. The meta-analysis yielded a pooled ablation efficacy rate of 97.11% (95% CI: 85.81–100.00%) and a pooled adverse event rate of 14.23% (95% CI: 8.07–20.38%), indicating favorable safety and efficacy of the combined therapy. Conclusions: The integration of surgical and ablative therapies offers a safe and effective strategy for managing MPLC and supports a potential paradigm shift from single-modality treatment toward a more personalized, organ-preserving, and patient-centered approach.
- Open Access
- 24 October 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-5
Solitary squamous cell carcinoma of the right chest wall following VATS lobectomy for NSCLC: A rare case report
Non-small cell lung cancer (NSCLC) with chest wall invasion is typically diagnosed at initial presentation, and nodal involvement (especially N2 station) correlates with poor prognosis. To our knowledge, this is the first report of a solitary squamous cell carcinoma of the right chest wall arising 21 months after video-assisted thoracoscopic surgery (VATS) lobectomy for left NSCLC (pT1bN0M0). Primary solitary chest wall squamous cell carcinoma in adults is poorly documented, with limited data on its clinical manifestations, pathology, and management. This case aims to enhance understanding of this rare entity, aiding in avoiding misdiagnosis and inappropriate treatment (Yin et al. in Med (Baltim) 2018;97(44):e13112).
- 24 October 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-5
Open AccessSolitary squamous cell carcinoma of the right chest wall following VATS lobectomy for NSCLC: A rare case report
Non-small cell lung cancer (NSCLC) with chest wall invasion is typically diagnosed at initial presentation, and nodal involvement (especially N2 station) correlates with poor prognosis. To our knowledge, this is the first report of a solitary squamous cell carcinoma of the right chest wall arising 21 months after video-assisted thoracoscopic surgery (VATS) lobectomy for left NSCLC (pT1bN0M0). Primary solitary chest wall squamous cell carcinoma in adults is poorly documented, with limited data on its clinical manifestations, pathology, and management. This case aims to enhance understanding of this rare entity, aiding in avoiding misdiagnosis and inappropriate treatment (Yin et al. in Med (Baltim) 2018;97(44):e13112).